CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
68 hedge funds and large institutions have $11M invested in Carisma Therapeutics in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
52% less capital invested
Capital invested by funds: $23.1M → $11M (-$12.1M)
Holders
68
Holding in Top 10
–
Calls
$892K
Puts
$836K
Top Buyers
| 1 | +$188K | |
| 2 | +$80K | |
| 3 | +$70K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$61K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$54K |
Top Sellers
| 1 | -$802K | |
| 2 | -$622K | |
| 3 | -$269K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$164K |
| 5 |
Goldman Sachs
New York
|
-$130K |